Trial Profile
Phase II trial of a Bruton's tyrosine kinase (BTK) inhibitor in patients with rheumatoid arthritis.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 04 Mar 2015
Price :
$35
*
At a glance
- Drugs Agammaglobulinaemia tyrosine kinase inhibitors (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Pharmacyclics
- 04 Mar 2015 New trial record